Minimal Residual Disease (MRD) By Either Flow Cytometry or Cytogenetics Prior to an Allogeneic Hematopoietic Cell Transplant (allo-HCT) Predicts Poor Acute Myeloid Leukemia (AML) Outcomes

Lakshmikanth Katragadda(University of Florida), John R. Wingard(University of Florida Health), Yunfeng Dai(University of Florida), Helen Leather(University of Florida), Lamis Eldjerou, Christopher R. Cogle(University of Florida), Jan S. Moreb(University of Florida), Ying Li(University of Florida), Myron Chang(University of Florida Health), Randy A. Brown(University of Florida), W. Stratford May(City of Cape Town), John W. Hiemenz(University of Florida), Maxim Norkin(Centre Hospitalier Universitaire Vaudois)
Blood
December 3, 2015
Cited by 0


Related Papers